Prenatal Sonographic Prediction of Placental Histology and Function
Endeavor Health · NCT06022458
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–60 · Women only
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 320
- US sites recruiting
- 1
- Study start
- May 28, 2024
- Record last updated
- July 23, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this two-phase observational study is to investigate the use of ultrasonography to predict placental pathology at the time of delivery.
Conditions: Pregnancy Complications
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Retrospective Phase
Inclusion criteria
- Patients with delivery in NorthShore University HealthSystem,
- Ultrasound available within 4 weeks of delivery with adequate placental images
- Placental pathology available
Exclusion criteria
- Multiple gestation
Prospective Phase Inclusion criteria
- Exposed: Patients with singleton gestation with fetal growth restriction at 20-28 weeks with a plan to deliver at NorthShore Highland Park Hospital Evanston Hospital. Patients must have a first-trimester ultrasound (\<14 weeks) to confirm pregnancy dating available in the electronic medical record.
- Unexposed: Patients who present for routine ultrasound evaluation at 36-38 weeks with normal fetal growth with a plan to deliver at NorthShore Highland Park Hospital or NorthShore Evanston Hospital.
Exclusion criteria
- Exposed: Multiple gestation, major fetal anomaly
- Unexposed: Multiple gestation, history of chronic hypertension, gestational or pregestational diabetes, major fetal anomaly antiphospholipid syndrome, known thrombophilia
Recruiting US locations
NorthShore University HealthSystem
Evanston, IL 60201
Site contact: Sunitha Suresh, MD
Study contacts (from the official record)
- Sunitha Suresh · 8475702860 · SSuresh@northshore.org
- Camilla Lee · (847) 570-4729 · JLee5@northshore.org
Similar studies in Illinois
All pregnancy studies in Illinois →- RecruitingPhase 3
A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
Janssen Research & Development, LLC
- Location
- Park Ridge, IL + 19 other US sites
- Eligibility basics
- Ages 18–45 · Women only
- RecruitingPhase 3
A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
Janssen Research & Development, LLC
- Location
- Park Ridge, IL + 11 other US sites
- Eligibility basics
- Ages 18–45 · Women only
- RecruitingPhase 3
Brexanolone Lifting Outcomes Of Moms
Lipocine Inc.
- Location
- Chicago, IL + 15 other US sites
- Eligibility basics
- Ages 15–45 · Women only
- Recruiting
Prenatal Study in Healthy Pregnant Women
Perelel Inc.
- Location
- Chicago, IL
- Eligibility basics
- Ages 21–40 · Women only